

Page 72
conferenceseries
.com
Volume 8
Journal of Palliative Care & Medicine
ISSN: 2165-7386
Geriatrics 2018
July 30-31, 2018
July 30-31, 2018 | Barcelona, Spain
8
th
International Conference on
Geriatrics Gerontology & Palliative Nursing
Dementia-related agitation: A review of non-drug interventions and analysis of risks and benefits of
drug therapy
Ezekiel O Ijaopo
East Kent Hospitals University Trust, UK
Unsurprisingly, the subject of dementia has been a rising matter of public health concerns as people now live longer. World
Alzheimer Report 2015, estimate that about 46.8 million people worldwide have dementia. These numbers are projected to
almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. The modality for treating agitation
and other behavioral symptoms in dementia patients has been a challenge. Many years on, there has been no FDA-approved
drug therapy in treating dementia-related agitation. This review discusses the current knowledge of non-drug interventions
and analyzes the risks and benefits of drug therapy in the management of dementia-related agitation, as well as providing an
anecdotal of the author’s clinical experience. This article aims to provide opportunity for increase awareness for clinicians;
particularly those with no specialty training in elderly care medicine, but, see dementia patients with agitation and other
behavioral symptoms from time to time. Likewise, it hopefully will benefit the readers of medical journals to update their
existing knowledge on matters relating to the management of dementia-related agitation.
Ezekiel.ijaopo@nhs.netJ Palliat Care Med 2018, Volume 8
DOI: 10.4172/2165-7386-C2-018